ATE400312T1 - Vorrichtung und verfahren zur qualitativen und quantitativen bestimmung von intravenösen flüssigkeitskomponenten - Google Patents

Vorrichtung und verfahren zur qualitativen und quantitativen bestimmung von intravenösen flüssigkeitskomponenten

Info

Publication number
ATE400312T1
ATE400312T1 AT03733835T AT03733835T ATE400312T1 AT E400312 T1 ATE400312 T1 AT E400312T1 AT 03733835 T AT03733835 T AT 03733835T AT 03733835 T AT03733835 T AT 03733835T AT E400312 T1 ATE400312 T1 AT E400312T1
Authority
AT
Austria
Prior art keywords
fluid components
qualitative
intravenous fluid
spectroscopic analysis
medication
Prior art date
Application number
AT03733835T
Other languages
English (en)
Inventor
Dean Owen Allgeyer
Original Assignee
Dean Owen Allgeyer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/264,666 external-priority patent/US6847899B2/en
Application filed by Dean Owen Allgeyer filed Critical Dean Owen Allgeyer
Application granted granted Critical
Publication of ATE400312T1 publication Critical patent/ATE400312T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/01Arrangements or apparatus for facilitating the optical investigation
    • G01N21/15Preventing contamination of the components of the optical system or obstruction of the light path
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M2005/1401Functional features
    • A61M2005/1405Patient controlled analgesia [PCA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/60General characteristics of the apparatus with identification means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01JMEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
    • G01J3/00Spectrometry; Spectrophotometry; Monochromators; Measuring colours
    • G01J3/02Details
    • G01J3/10Arrangements of light sources specially adapted for spectrometry or colorimetry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/65Raman scattering
    • G01N2021/651Cuvettes therefore
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/65Raman scattering

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pathology (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Examining Or Testing Airtightness (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
AT03733835T 2002-10-04 2003-03-03 Vorrichtung und verfahren zur qualitativen und quantitativen bestimmung von intravenösen flüssigkeitskomponenten ATE400312T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/264,666 US6847899B2 (en) 2002-04-26 2002-10-04 Device and method for qualitative and quantitative determination of intravenous fluid components

Publications (1)

Publication Number Publication Date
ATE400312T1 true ATE400312T1 (de) 2008-07-15

Family

ID=32092358

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03733835T ATE400312T1 (de) 2002-10-04 2003-03-03 Vorrichtung und verfahren zur qualitativen und quantitativen bestimmung von intravenösen flüssigkeitskomponenten

Country Status (5)

Country Link
EP (1) EP1545659B1 (de)
AT (1) ATE400312T1 (de)
AU (1) AU2003239122A1 (de)
DE (1) DE60322084D1 (de)
WO (1) WO2004033003A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7417729B2 (en) * 2003-11-07 2008-08-26 Cardinal Health 303, Inc. Fluid verification system and method for infusions
CN101010112B (zh) * 2004-09-02 2010-04-21 诺和诺德公司 适于检测药物状态的医用卫生器材
ZA200805012B (en) 2005-11-29 2009-11-25 Klein Medical Ltd Syringe for use in spectroscopy
US8094307B2 (en) 2007-07-05 2012-01-10 Baxter International Inc. Method and apparatus for measuring the presence and concentration of pharmaceutical substances in a medical fluid administered by a medication delivery system
WO2009114115A1 (en) 2008-03-10 2009-09-17 S.E.A. Medical Systems, Inc. Intravenous fluid monitoring
US9052276B2 (en) 2009-06-08 2015-06-09 S.E.A. Medical Systems, Inc. Systems and methods for the identification of compounds using admittance spectroscopy
CN102460137A (zh) 2009-06-08 2012-05-16 S.E.A.医疗系统公司 用于使用导纳谱法鉴定医用流体中的化合物的系统和方法
BR112013005720A2 (pt) 2010-09-09 2019-09-24 S E A Medical Systems Inc sensor para espectroscopia de imitância, sistemas de espectroscopia de imitância e para acumular e identificar resíduos de medicamentos, métodos método de determinar a identidade e/ou concentração de um medicamento, de acumular e identificar resíduo de medicamento, de determinar a identidade e concentração de um medicamento e para precisamente e automaticamente suprir um medicamento, e, sistema médico totalmente automatizado
US9155833B2 (en) 2011-03-04 2015-10-13 Becton, Dickinson And Company Systems and methods for monitoring the use of medications
WO2012138236A1 (en) 2011-04-06 2012-10-11 Krouse Donal Paul Spectroscopic analyser
WO2013191566A1 (en) 2012-06-19 2013-12-27 Klein Medical Limited Spectroscopic analysis
DE102012111480A1 (de) 2012-06-22 2013-12-24 B. Braun Melsungen Ag Verfahren und Vorrichtung zum Prüfen mindestens eines Fluids
EP3250259B1 (de) 2015-01-27 2019-11-13 Pharmacolog i Uppsala AB Verfahren und system zur dosisratenregulierung in der medikamenteninfusionsbehandlung
DE102017108120A1 (de) 2017-04-13 2018-10-18 Laser-Laboratorium Göttingen e.V. Analysevorrichtung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19545598A1 (de) * 1995-12-06 1997-06-26 Messer Griesheim Gmbh Analytische Konfiguration zur Überwachung von Xenon-haltigem Narkosegas
WO1998019592A1 (en) * 1996-11-01 1998-05-14 Rio Grande Medical Technologies, Inc. Dialysis monitoring method and apparatus
EP0990255A1 (de) * 1997-06-03 2000-04-05 Arqule, Inc. Automatisiertes verfahren mit hohem durchsatz zur untersuchung von proben mittels massenspektrometrie
US6261262B1 (en) * 1997-06-12 2001-07-17 Abbott Laboratories Pump with anti-free flow feature
US6111639A (en) * 1998-05-06 2000-08-29 Reduto; Lawrence A. Method and apparatus for countering adverse drug events
SE525639C2 (sv) * 1998-06-04 2005-03-22 Thore Falkvall Bestämning av slaggprodukter i dialysvätska med hjälp av optisk sensor

Also Published As

Publication number Publication date
EP1545659A1 (de) 2005-06-29
AU2003239122A1 (en) 2004-05-04
WO2004033003A1 (en) 2004-04-22
EP1545659B1 (de) 2008-07-09
DE60322084D1 (de) 2008-08-21

Similar Documents

Publication Publication Date Title
ATE400312T1 (de) Vorrichtung und verfahren zur qualitativen und quantitativen bestimmung von intravenösen flüssigkeitskomponenten
NO20053961D0 (no) Analyse-system for en loggeinnretning for handtering av og hendelser i forbindelse med medisering
PL374285A1 (en) System and method for operating medical devices
BR9509531A (pt) Espaçador dosimétrico
ATE482744T1 (de) Vorrichtung zur erkennung und behandlung von depressionen
SG146653A1 (en) Methods and reagents for the treatment of immunoinflammatory disorders
DE60011274D1 (de) Verfahren, reagenz und messkartusche zur bestimmung der gerinnungszeit
DE502004012409D1 (de) Vorrichtung zur extrakorporalen Blutbehandlung mit einer Einrichtung zur Überprüfung eines Sterilfilters und Verfahren zum Überprüfen eines Sterilfilters einer extrakorporalen Blutbehandlungsvorrichtung
ATE181422T1 (de) Verfahren zur diagnose von praeklampsie
EP1634060B1 (de) Verfahren und Vorrichtung zur Analyse, Verifizierung und Qualitätssicherung von Arzneistoffen zur Infusion
WO2002095358A3 (en) System and method for monitoring or treating a health condition
WO2004021863A3 (en) Methods for measuring rates of replication and death of nfectious microbial agents in an infected host organism
ATE405211T1 (de) Verfahren zur überprüfung von einem diabetischen fuss
EP1739585B1 (de) Verfahren zur Identifizierung von Medikamenten, vor Verabreichung
JPS5964051A (ja) 管組立体
EP2593790A2 (de) Verfahren und systeme zur in-vivo-messung klinischer daten von analyten
McBay Propoxyphene and norpropoxyphene concentrations in blood and tissues in cases of fatal overdose.
JP2019515035A5 (de)
Florez et al. Clinical pharmacokinetic (PK) and safety (immunogenicity) of rituximab biosimilar RTXM83 in combination with chemotherapy CHOP in patients with diffuse large B-cell lymphoma (DLBCL)
Naik et al. Review of Clinical Pharmacology Information for Peptides Found in US FDA Drug Labeling
DE602004016547D1 (de) 1,4-dihydropyridinverbindungen, pharmazeutische verbindungen, und verfahren zur behandlung von herzkreislauferkrankungen
Ussov et al. Quantification of breast cancer blood flow in absolute units using Gjedde-Rutland-Patlak analysis of 99mTc-MIBI uptake
Beauregard et al. Opioid-positive urine drug screen during treatment with oral naltrexone and the clinical implications
Kain et al. Developing guidelines for syringe driver management
SU1388048A1 (ru) Способ лечени хронического гепатита стрептокиназосодержащими препаратами и гепарином

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties